Literature DB >> 17568135

Lentivirus-mediated gene expression.

Jing Zhao1, Andrew M L Lever.   

Abstract

Lentiviruses have the capacity to enter and integrate their genetic material into cells that are not dividing. This property is retained in vectors based on these agents. They can thus effect gene delivery to cells that are difficult to transduce such as cardiac myocytes in vitro and in vivo. They are also relatively efficient at entering dividing cells and can transduce stem cells and vascular endothelium. They have a substantial gene-carrying capacity of up to around 9 kb. They do not trigger an inflammatory response and are thus useful when proinflammatory agents are undesirable, such as in transplantation. Their ease of cloning and well-understood molecular biology have made them highly suitable for gene delivery to the heart.

Mesh:

Year:  2007        PMID: 17568135     DOI: 10.1007/978-1-59745-030-0_20

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Gene therapy in epilepsy.

Authors:  Véronique Riban; Helen L Fitzsimons; Matthew J During
Journal:  Epilepsia       Date:  2008-08-19       Impact factor: 5.864

2.  Gene therapy for Parkinson's disease.

Authors:  Rachel Denyer; Michael R Douglas
Journal:  Parkinsons Dis       Date:  2012-03-25

3.  Large-scale production of lentiviral vector in a closed system hollow fiber bioreactor.

Authors:  Jonathan Sheu; Jim Beltzer; Brian Fury; Katarzyna Wilczek; Steve Tobin; Danny Falconer; Jan Nolta; Gerhard Bauer
Journal:  Mol Ther Methods Clin Dev       Date:  2015-06-17       Impact factor: 6.698

4.  Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.

Authors:  Yajuan Qian; Ziyan Du; Yufei Xing; Tong Zhou; Ting Chen; Minhua Shi
Journal:  Mol Med Rep       Date:  2017-08-22       Impact factor: 2.952

5.  Data regarding transplant induced germinal center humoral autoimmunity.

Authors:  M Saeed Qureshi; Jawaher Alsughayyir; Manu Chhabra; Jason M Ali; Martin J Goddard; Chris Devine; Thomas M Conlon; Michelle A Linterman; Reza Motallebzadeh; Gavin J Pettigrew
Journal:  Data Brief       Date:  2018-12-28

Review 6.  Nanomedicine for Gene Delivery for the Treatment of Cardiovascular Diseases.

Authors:  Cen Yan; Xiao-Jiang Quan; Ying-Mei Feng
Journal:  Curr Gene Ther       Date:  2019       Impact factor: 4.391

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.